InvAscent scores lofty returns from vitamins maker in second exit of 2021

 InvAscent scores lofty returns from vitamins maker in second exit of 2021
Healthcare-focused private equity firm InvAscent has struck spectacular returns by selling its stake in probiotic and Vitamin K supplement maker Synergia Life Sciences Pte. Ltd via a secondary buyout deal. Danish biotechnology company Novozyme A/S recently announced it was acquiring 60% of all outstanding shares of Synergia Life Sciences for […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Ankit Doshi

error: Content is protected !!
The Capital Quest